MAP1B Antikörper (AA 2050-2100)
Kurzübersicht für MAP1B Antikörper (AA 2050-2100) (ABIN7452223)
Target
Alle MAP1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2050-2100
-
Verwendungszweck
- Rabbit anti-MAP1B Antibody, Affinity Purified
-
Aufreinigung
- Affinity Purified
-
Immunogen
- between AA 2050 and 2100
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IP: 2 - 5 μg/mg lysate
WB: Not recommended. ABIN7452223 has not performed satisfactorily when used for WB of MAP1B in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of MAP1B.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- MAP1B (Microtubule-Associated Protein 1B (MAP1B))
-
Andere Bezeichnung
- MAP1B
-
Hintergrund
- Background: MAP1B is one of the founding members of the MAP (microtubule-associated protein) family of proteins involved in microtubule assembly. MAP1B is almost exclusively expressed in the developing brain and is critical for axon formation. MAP1B-null mice exhibit an absence of the corpus collosum and impaired axon development. MAP1B is processed by proteolytic cleavage that leads to the generation of a 300 kDa heavy chain and a 32 kDa LC1 light chain.
-
Gen-ID
- 4131
-
NCBI Accession
- NP_005900
-
UniProt
- P46821
-
Pathways
- Microtubule Dynamics, Regulation of Cell Size
Target
-